Update on the Closed-Loop Artificial Pancreas Project Stuart A Weinzimer, MD Associate Professor of Pediatrics Yale University School of Medicine CWD Friends.
Are We There Yet? Eda Cengiz, MD, MHS Assistant Professor of Pediatrics Yale University School of Medicine Update on Artificial Pancreas Project.
Telemedical Disease Management in Europe: What are the Chances and Risks Dr. med. Andy Fischer, Swiss Center for Telemedicine MEDGATE Med _e_Tel, Luxembourg,
At GP surgery: BGL 25mmol/L – referred to ED In ED: Capillary blood gas: pH 7.18, bicarbonate (HCO3) 12 mmol/L, BGL 25 mmol/L, Na 136 mmol/L (corrected.
1 Type 1 Diabetes Mellitus Treatment. 2 Goals of T1DM Management Utilize intensive therapy aimed at near-normal BG and A1C levels Prevent diabetic ketoacidosis.
Importance of Ancillary Supplies for Subcutaneous Immunoglobulin Infusion: Management of the Local Infusion Site Diane Ochoa, 1* Christine Curtis, 2 Carla.
Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.
*Current affiliation is Maxim Healthcare, Dallas, TX
INTRODUCTION
INTRODUCTION The Solution: Point-of-care (POC) continuous glucose sensors offer significant promise for real-time control and artificial pancreas systems.
Bydureon ® (exenatide once weekly) clinical data slide deck Developed with the guidance and approval of an independent international editorial committee.
